The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be

Study Name on
ClinicalTrials.gov (link is external)
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)
Study DrugAmikacin/ Tigecycline/ Imipenem/ Cefoxitin/ Azithromycin/ Clarithromycin/ Clofazimine/ Ethambutol/ Linezolid/ co-trimoxazole/ Doxycycline/ Moxifloxacin/ Bedaquiline/ Rifabutin
Type of Study DrugAnti-Infective
Study TitleFinding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)
Study Phase2 and 3
Study SponsorThe University of Queensland

Link on
clinicaltrials.gov (link is external)

https://clinicaltrials.gov/ct2/show/NCT04310930

Participating ECFS-CTN sitesPlease contact ecfs-ctn@uzleuven.be for most recent sitelist
AgePediatric and Adult patients